106 related articles for article (PubMed ID: 15250153)
1. [Experimental research into the inhibitory effect of 131I-recombinant human epidermal growth factor on the growth of breast cancer in vivo].
Li Y; Xu W; Tan T; He S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):444-8. PubMed ID: 15250153
[TBL] [Abstract][Full Text] [Related]
2. [Radiobiological effect of 131I radiolabeled recombinant human epidermal growth factor on nude mice with human breast cancer].
Li Y; Xu W; Tan T; He S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):749-53. PubMed ID: 16156265
[TBL] [Abstract][Full Text] [Related]
3. 131I-recombinant human EGF has antitumor effects against MCF-7 human breast cancer xenografts with low levels of EGFR.
Li YC; Xu WY; Tan TZ; He S
Nucl Med Biol; 2004 May; 31(4):435-40. PubMed ID: 15093813
[TBL] [Abstract][Full Text] [Related]
4. Effects of epidermal growth factor on the growth of human gastric cancer cell and the implanted tumor of nude mice.
Xia L; Yuan YZ; Xu CD; Zhang YP; Qiao MM; Xu JX
World J Gastroenterol; 2002 Jun; 8(3):455-8. PubMed ID: 12046069
[TBL] [Abstract][Full Text] [Related]
5. [Effect of 131I-labeled recombinant human tumor necrosis factor-alpha on the nude mice bearing human hepatoma].
Long YH; Li YC; Mi YX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):787-92. PubMed ID: 19950584
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and application of 131I-fulvestrant as a targeted radiation drug for endocrine therapy in human breast cancer.
Yin G; Zeng B; Peng Z; Liu Y; Sun L; Liu C
Oncol Rep; 2018 Mar; 39(3):1215-1226. PubMed ID: 29328488
[TBL] [Abstract][Full Text] [Related]
7. Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection.
Li CC; Chi JL; Ma Y; Li JH; Xia CQ; Li L; Chen Z; Chen XL
Radiat Oncol; 2014 Jun; 9():144. PubMed ID: 24958442
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study of targeting therapy of breast cancer with 131I-labeled epidermal growth factor].
Xu WY; Li YC; He S; Zhao YB; Li HJ; Yao XY
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):14-7. PubMed ID: 15774166
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis.
Ryu SH; Kang KM; Moon SY; Chai GY; Hong JP; Cho KO; Kang MI; Choi EK; Lee SW
J Radiat Res; 2010; 51(5):595-601. PubMed ID: 20921827
[TBL] [Abstract][Full Text] [Related]
10. Growth regulation by estradiol, progesterone and recombinant human epidermal growth factor of human breast carcinoma xenografts grown serially in nude mice.
Kubota T; Josui K; Fukutomi T; Kitajima M
Anticancer Res; 1995; 15(4):1275-8. PubMed ID: 7654008
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
12. A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice.
Gainza G; Pastor M; Aguirre JJ; Villullas S; Pedraz JL; Hernandez RM; Igartua M
J Control Release; 2014 Jul; 185():51-61. PubMed ID: 24794895
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study of bio-distribution and tumor imaging of 131I in nude mice bearing human breast cancer].
Fan W; Wang GH; Yang MT; Zhang WG; Dai JJ; Yang XC
Ai Zheng; 2004 Jul; 23(7):808-11. PubMed ID: 15248917
[TBL] [Abstract][Full Text] [Related]
14. Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
Hardwicke J; Ferguson EL; Moseley R; Stephens P; Thomas DW; Duncan R
J Control Release; 2008 Sep; 130(3):275-83. PubMed ID: 18700156
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human epidermal growth factor (rhEGF) protects radiation-induced intestine injury in murine system.
Oh H; Seong J; Kim W; Park S; Koom WS; Cho NH; Song M
J Radiat Res; 2010; 51(5):535-41. PubMed ID: 20657160
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the effects of recombinant human epidermal growth factor and basic fibroblast growth factor on corneal epithelial wound healing and neovascularization in vivo and in vitro.
Yan L; Wu W; Wang Z; Li C; Lu X; Duan H; Zhou J; Wang X; Wan P; Song Y; Tang J; Han Y
Ophthalmic Res; 2013; 49(3):150-60. PubMed ID: 23258255
[TBL] [Abstract][Full Text] [Related]
17. [Research for the production of recombinant human epidermal growth factor using Samia Cynthia Ricini pupae bioreactor].
Wu Y; Huang Y; Lei D; Wu Y; Li M; Kobayashi J; Wang X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Feb; 30(1):136-40. PubMed ID: 23488154
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human epidermal growth factor accelerates recovery of mouse small intestinal mucosa after radiation damage.
Lee KK; Jo HJ; Hong JP; Lee SW; Sohn JS; Moon SY; Yang SH; Shim H; Lee SH; Ryu SH; Moon SR
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1230-5. PubMed ID: 18572086
[TBL] [Abstract][Full Text] [Related]
19. Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.
Li W; Liu Z; Li C; Li N; Fang L; Chang J; Tan J
J Cancer Res Clin Oncol; 2016 Mar; 142(3):619-32. PubMed ID: 26573511
[TBL] [Abstract][Full Text] [Related]
20. The preventive effect of recombinant human growth factor (rhEGF) on the recurrence of radiodermatitis.
Ryu SH; Kim YH; Lee SW; Hong JP
J Radiat Res; 2010; 51(5):511-7. PubMed ID: 20657159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
